消化系统恶性肿瘤免疫治疗的研究进展.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 1, p. 80, doi. 10.3872/j.issn.1007-385x.2022.01.013
- By:
- Publication type:
- Article
Works matching IS 1007385X AND DT 2022 AND VI 29 AND IP 1
Results: 13
1
2
T细胞糖代谢重编程与抗肿瘤免疫治疗的研究进展.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 1, p. 75, doi. 10.3872/j.issn.1007-385x.2022.01.012
- By:
- Publication type:
- Article
3
肿瘤来源外泌体在诱导肿瘤相关成纤维细胞生成中作用的研究进展.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 1, p. 70, doi. 10.3872/j.issn.1007-385x.2022.01.011
- By:
- Publication type:
- Article
4
氨基酸代谢在肿瘤微环境及免疫治疗中作用的研究进展.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 1, p. 63, doi. 10.3872/j.issn.1007-385x.2022.01.010
- By:
- Publication type:
- Article
5
基于生物信息学分析METTL7B在胶质瘤组织中的表达及其临床意义.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 1, p. 55, doi. 10.3872/j.issn.1007-385x.2022.01.009
- By:
- Publication type:
- Article
6
甲状腺滤泡癌组织中PD-1 和NLRP3 表达及其临床意义.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 1, p. 50, doi. 10.3872/j.issn.1007-385x.2022.01.008
- By:
- Publication type:
- Article
7
桥接整合因子1 在上皮性卵巢癌组织和细胞中的表达及其临床意义.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 1, p. 43, doi. 10.3872/j.issn.1007-385x.2022.01.007
- By:
- Publication type:
- Article
8
miR-502-3p通过靶向GTPBP2 基因调控结直肠癌干细胞增殖与凋亡.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 1, p. 37, doi. 10.3872/j.issn.1007-385x.2022.01.006
- By:
- Publication type:
- Article
9
miR-17-5p 通过靶向SETD2 调控骨髓增生异常综合征SKM-1 细胞的增 殖与凋亡.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 1, p. 30, doi. 10.3872/j.issn.1007-385x.2022.01.005
- By:
- Publication type:
- Article
10
miR-875-5p通过靶向USF2 抑制胃癌细胞的增殖、迁移和侵袭.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 1, p. 23, doi. 10.3872/j.issn.1007-385x.2022.01.004
- By:
- Publication type:
- Article
11
MLL5 基因敲除对小鼠结肠癌CT26 细胞移植瘤生长的影响及其机制.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 1, p. 18, doi. 10.3872/j.issn.1007-385x.2022.01.003
- By:
- Publication type:
- Article
12
shRNA靶向抑制CD38 的抗CD38 CAR-T细胞构建及其功能的初步鉴定.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 1, p. 11, doi. 10.3872/j.issn.1007-385x.2022.01.002
- By:
- Publication type:
- Article
13
个性化新抗原肿瘤疫苗：道阻且长, 未来可期.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 1, p. 1, doi. 10.3872/j.issn.1007-385x.2022.01.001
- By:
- Publication type:
- Article